Managing functional disturbances in patients with inflammatory bowel disease

Philip M. Ginsburg, Theodore M Bayless

Research output: Contribution to journalArticle

Abstract

Functional disturbances occur in approximately 10% to 15% of the general population and in a similar percentage of patients with inflammatory bowel disease (IBD). Because overlapping irritable bowel syndrome (IBS) is so common, one of the most important interventions a clinician can make is recognizing its existence. This requires a thorough understanding of underlying pathophysiologic processes. Differentiating among the causes of symptoms is especially significant in a minority of patients mislabeled as having 'refractory IBD.' Escalating therapy directed at disease activity may have no effect on functional symptoms other than to reinforce their presence. Treatment of IBS in patients with IBD is similar to that of the general population. The cornerstone of treatment is establishing a constructive doctor-patient relationship. Initial therapy usually involves a conservative approach that includes patient education and diet and lifestyle modifications. Pharmacologic treatment is individualized and generally directed at the predominant symptoms. Options may broadly include antispasmodics, antidiarrheals, and antidepressants, either alone or in combination. Psychosocial therapies have shown to be beneficial in selected individuals.

Original languageEnglish (US)
Pages (from-to)211-221
Number of pages11
JournalCurrent Treatment Options in Gastroenterology
Volume8
Issue number3
StatePublished - Jun 2005

Fingerprint

Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Therapeutics
Antidiarrheals
Diet Therapy
Parasympatholytics
Patient Education
Antidepressive Agents
Population
Life Style

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Managing functional disturbances in patients with inflammatory bowel disease. / Ginsburg, Philip M.; Bayless, Theodore M.

In: Current Treatment Options in Gastroenterology, Vol. 8, No. 3, 06.2005, p. 211-221.

Research output: Contribution to journalArticle

@article{f764a101a7fb4c3aafc37d62a09459ce,
title = "Managing functional disturbances in patients with inflammatory bowel disease",
abstract = "Functional disturbances occur in approximately 10{\%} to 15{\%} of the general population and in a similar percentage of patients with inflammatory bowel disease (IBD). Because overlapping irritable bowel syndrome (IBS) is so common, one of the most important interventions a clinician can make is recognizing its existence. This requires a thorough understanding of underlying pathophysiologic processes. Differentiating among the causes of symptoms is especially significant in a minority of patients mislabeled as having 'refractory IBD.' Escalating therapy directed at disease activity may have no effect on functional symptoms other than to reinforce their presence. Treatment of IBS in patients with IBD is similar to that of the general population. The cornerstone of treatment is establishing a constructive doctor-patient relationship. Initial therapy usually involves a conservative approach that includes patient education and diet and lifestyle modifications. Pharmacologic treatment is individualized and generally directed at the predominant symptoms. Options may broadly include antispasmodics, antidiarrheals, and antidepressants, either alone or in combination. Psychosocial therapies have shown to be beneficial in selected individuals.",
author = "Ginsburg, {Philip M.} and Bayless, {Theodore M}",
year = "2005",
month = "6",
language = "English (US)",
volume = "8",
pages = "211--221",
journal = "Current Treatment Options in Gastroenterology",
issn = "1092-8472",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Managing functional disturbances in patients with inflammatory bowel disease

AU - Ginsburg, Philip M.

AU - Bayless, Theodore M

PY - 2005/6

Y1 - 2005/6

N2 - Functional disturbances occur in approximately 10% to 15% of the general population and in a similar percentage of patients with inflammatory bowel disease (IBD). Because overlapping irritable bowel syndrome (IBS) is so common, one of the most important interventions a clinician can make is recognizing its existence. This requires a thorough understanding of underlying pathophysiologic processes. Differentiating among the causes of symptoms is especially significant in a minority of patients mislabeled as having 'refractory IBD.' Escalating therapy directed at disease activity may have no effect on functional symptoms other than to reinforce their presence. Treatment of IBS in patients with IBD is similar to that of the general population. The cornerstone of treatment is establishing a constructive doctor-patient relationship. Initial therapy usually involves a conservative approach that includes patient education and diet and lifestyle modifications. Pharmacologic treatment is individualized and generally directed at the predominant symptoms. Options may broadly include antispasmodics, antidiarrheals, and antidepressants, either alone or in combination. Psychosocial therapies have shown to be beneficial in selected individuals.

AB - Functional disturbances occur in approximately 10% to 15% of the general population and in a similar percentage of patients with inflammatory bowel disease (IBD). Because overlapping irritable bowel syndrome (IBS) is so common, one of the most important interventions a clinician can make is recognizing its existence. This requires a thorough understanding of underlying pathophysiologic processes. Differentiating among the causes of symptoms is especially significant in a minority of patients mislabeled as having 'refractory IBD.' Escalating therapy directed at disease activity may have no effect on functional symptoms other than to reinforce their presence. Treatment of IBS in patients with IBD is similar to that of the general population. The cornerstone of treatment is establishing a constructive doctor-patient relationship. Initial therapy usually involves a conservative approach that includes patient education and diet and lifestyle modifications. Pharmacologic treatment is individualized and generally directed at the predominant symptoms. Options may broadly include antispasmodics, antidiarrheals, and antidepressants, either alone or in combination. Psychosocial therapies have shown to be beneficial in selected individuals.

UR - http://www.scopus.com/inward/record.url?scp=21044451908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21044451908&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 211

EP - 221

JO - Current Treatment Options in Gastroenterology

JF - Current Treatment Options in Gastroenterology

SN - 1092-8472

IS - 3

ER -